Delta sleep-inducing peptide studied in sleep-regulation models.
For research use only. Not for human or veterinary use. No claims of safety, efficacy or therapeutic benefit.
Sleep regulation and sleep architecture; sleep latency and efficiency have been assessed. A small double-blind insomnia study found weak effects and no improvement in subjective sleep quality, not a reliable insomnia-treatment benefit.
Human evidence cited here is small or exploratory and specific to the studied population and preparation. It does not establish efficacy of the Avitus product.
PMID: 1299794
Contact the Avitus team to confirm available presentations, product specifications and pricing for your research requirements.